• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平与氢氯噻嗪对高血压患者钙调节激素及骨密度的比较性影响

Comparative effects of nitrendipine and hydrochlorothiazide on calciotropic hormones and bone density in hypertensive patients.

作者信息

Giles T D, Sander G E, Roffidal L E, Quiroz A C, Mazzu A L

机构信息

Department of Medicine, Louisiana State University School of Medicine, New Orleans 70112.

出版信息

Am J Hypertens. 1992 Dec;5(12 Pt 1):875-9. doi: 10.1093/ajh/5.12.875.

DOI:10.1093/ajh/5.12.875
PMID:1285936
Abstract

The effects of the calcium antagonist nitrendipine and the diuretic hydrochlorothiazide on plasma calciotropic hormone concentrations and lumbar bone density were compared during the treatment of hypertension in a randomized, double-blind, 8 week parallel study, followed by a 52 week open label study. There were 32 subjects with stable essential hypertension (sitting diastolic blood pressure > or = 95 mm Hg and < or = 115 mm Hg without medication) without evidence of renal insufficiency or active heart disease. They were randomly assigned to receive either 10 mg nitrendipine twice daily or 50 mg hydrochlorothiazide daily. In order to reach and maintain target blood pressure (diastolic blood pressure < or = 95 mm Hg) during the open label period, the nitrendipine dose was titrated up to 30 mg twice daily, and additional antihypertensive drugs, of differing classes, were added as necessary. Blood samples were analyzed for concentrations of calcium, parathyroid hormone, and calcitonin, and lumbar bone density was determined by dual photon absorptiometry, at the baseline and at 24 and 52 weeks of antihypertensive drug therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在一项随机、双盲、为期8周的平行研究及随后为期52周的开放标签研究中,比较了钙拮抗剂尼群地平和利尿剂氢氯噻嗪在高血压治疗期间对血浆钙调节激素浓度和腰椎骨密度的影响。共有32例原发性高血压病情稳定(坐位舒张压≥95 mmHg且≤115 mmHg,未用药)且无肾功能不全或活动性心脏病证据的患者。他们被随机分配,分别每日两次服用10 mg尼群地平或每日服用50 mg氢氯噻嗪。为了在开放标签期达到并维持目标血压(舒张压≤95 mmHg),尼群地平剂量滴定至每日两次30 mg,并根据需要添加不同类别的其他降压药物。在基线以及抗高血压药物治疗24周和52周时,采集血样分析钙、甲状旁腺激素和降钙素的浓度,并通过双能光子吸收法测定腰椎骨密度。(摘要截选至250字)

相似文献

1
Comparative effects of nitrendipine and hydrochlorothiazide on calciotropic hormones and bone density in hypertensive patients.硝苯地平与氢氯噻嗪对高血压患者钙调节激素及骨密度的比较性影响
Am J Hypertens. 1992 Dec;5(12 Pt 1):875-9. doi: 10.1093/ajh/5.12.875.
2
Comparison of nitrendipine and hydrochlorothiazide for systemic hypertension.硝苯地平与氢氯噻嗪治疗系统性高血压的比较。
Am J Cardiol. 1987 Jul 1;60(1):103-6. doi: 10.1016/0002-9149(87)90994-5.
3
Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.氢氯噻嗪、阿替洛尔、尼群地平和依那普利在抗高血压治疗中的随机、双盲、多中心比较:HANE研究结果。HANE试验研究组
BMJ. 1997 Jul 19;315(7101):154-9. doi: 10.1136/bmj.315.7101.154.
4
The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.钙通道阻滞剂尼群地平在单药及联合用药抗高血压治疗方案中的应用:一项多中心研究的初步报告
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1077-84.
5
Calcium antagonists and thiazide diuretics have opposite effects on blood rheology and radial artery compliance in arterial hypertension: a randomized double-blind study.钙拮抗剂和噻嗪类利尿剂对高血压患者的血液流变学和桡动脉顺应性具有相反的作用:一项随机双盲研究。
Fundam Clin Pharmacol. 1998;12(4):457-62. doi: 10.1111/j.1472-8206.1998.tb00972.x.
6
Effects of nitrendipine and hydrochlorothiazide on postprandial blood pressure reduction and carbohydrate metabolism in hypertensive patients over 70 years of age.尼群地平和氢氯噻嗪对70岁以上高血压患者餐后血压降低及碳水化合物代谢的影响。
J Cardiovasc Pharmacol. 1988;12 Suppl 4:S59-63. doi: 10.1097/00005344-198806124-00011.
7
Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.尼群地平的抗高血压治疗:与氢氯噻嗪和普萘洛尔的比较。
J Cardiovasc Pharmacol. 1988;12 Suppl 4:S55-8.
8
Synergism of hydrochlorothiazide and nitrendipine on reduction of blood pressure and blood pressure variability in spontaneously hypertensive rats.
Acta Pharmacol Sin. 2006 Dec;27(12):1575-9. doi: 10.1111/j.1745-7254.2006.00366.x.
9
Prolonged calcium channel blocker therapy of hypertension.高血压的长期钙通道阻滞剂治疗。
J Cardiovasc Pharmacol. 1988;12 Suppl 4:S16-21. doi: 10.1097/00005344-198806124-00005.
10
Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.通过24小时动态血压监测评估依那普利10毫克/尼群地平20毫克固定剂量复方制剂与氯沙坦50毫克/氢氯噻嗪12.5毫克对原发性高血压患者的降压效果比较。
J Hum Hypertens. 2004 Mar;18(3):215-22. doi: 10.1038/sj.jhh.1001655.

引用本文的文献

1
Predicting re-fracture risk factors in older adult osteoporotic vertebral fractures patients with comorbidities: development and validation of nomogram.
Front Med (Lausanne). 2025 Oct 24;12:1664157. doi: 10.3389/fmed.2025.1664157. eCollection 2025.
2
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE Trial.肾结石患者中氢氯噻嗪与骨矿物质密度:NOSTONE试验的事后分析
Clin J Am Soc Nephrol. 2025 May 1;20(5):706-718. doi: 10.2215/CJN.0000000659. Epub 2025 Mar 10.
3
Thiazide Diuretics and Fracture Risk: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.噻嗪类利尿剂与骨折风险:随机临床试验的系统评价与荟萃分析
JBMR Plus. 2022 Oct 7;6(11):e10683. doi: 10.1002/jbm4.10683. eCollection 2022 Nov.
4
Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies.超越常规降压策略:治疗考量与联合疗法
J Clin Hypertens (Greenwich). 2001 Nov-Dec;3(6):346-53. doi: 10.1111/j.1524-6175.2001.00469.x.